SummaryBackgroundGram-negative Enterobacteriaceae with resistance to carbapenem conferred by New Delhi metallo-β-lactamase 1 (NDM-1) are potentially a major global health problem. We investigated the prevalence of NDM-1, in multidrug-resistant Enterobacteriaceae in India, Pakistan, and the UK.MethodsEnterobacteriaceae isolates were studied from two major centres in India—Chennai (south India), Haryana (north India)—and those referred to the UK's national reference laboratory. Antibiotic susceptibilities were assessed, and the presence of the carbapenem resistance gene blaNDM-1 was established by PCR. Isolates were typed by pulsed-field gel electrophoresis of XbaI-restricted genomic DNA. Plasmids were analysed by S1 nuclease digestion and PCR typing. Case data for UK patients were reviewed for evidence of travel and recent admission to hospitals in India or Pakistan.FindingsWe identified 44 isolates with NDM-1 in Chennai, 26 in Haryana, 37 in the UK, and 73 in other sites in India and Pakistan. NDM-1 was mostly found among Escherichia coli (36) and Klebsiella pneumoniae (111), which were highly resistant to all antibiotics except to tigecycline and colistin. K pneumoniae isolates from Haryana were clonal but NDM-1 producers from the UK and Chennai were clonally diverse. Most isolates carried the NDM-1 gene on plasmids: those from UK and Chennai were readily transferable whereas those from Haryana were not conjugative. Many of the UK NDM-1 positive patients had travelled to India or Pakistan within the past year, or had links with these countries.InterpretationThe potential of NDM-1 to be a worldwide public health problem is great, and co-ordinated international surveillance is needed.FundingEuropean Union, Wellcome Trust, and Wyeth.
A new multiplex PCR assay was developed to separate the four major Listeria monocytogenes serovars isolated from food and patients (1/2a, 1/2b, 1/2c, and 4b) into distinct groups. The PCR test, which constitutes a rapid and practical alternative to laborious classical serotyping, was successfully evaluated with 222 Listeria strains.Listeria monocytogenes is a facultative intracellular pathogen that can cause serious illness in susceptible individuals. Persons with specific immunocompromising conditions, pregnant women, newborns, and the elderly are particularly at risk for listeriosis (9, 23). Although rare, listeriosis remains of great public health concern due to its high mortality rate (20 to 30%) (16). Ingestion of contaminated foods is considered to be the primary source of infection for both sporadic and epidemic human listeriosis cases (19). Because of the importance of L. monocytogenes strain characterizations for epidemiological investigations, a number of discriminatory subtyping methods have been described for this organism (2,4,5,18,20,24,25). Pulsed-field gel electrophoresis (PFGE) typing, which has provided the most sensitive strain discrimination up to now, has rapidly become the standard subtyping method to detect listeriosis outbreaks (4, 11). However, this method is labor-intensive and time-consuming and thus for practical purposes is often preceded by serotyping. Since all major outbreaks of the invasive form of listeriosis are due to serovar 4b strains, an infrequent serovar in foods compared to 1/2a strains (6, 9), the procedure adopted for outbreak investigations relies upon serovar characterization to provide valuable information for rapid screening of groups of strains. Indeed, the serovar information allows discrimination between isolates probably belonging to an outbreak and those that are not part of the outbreak and thus decreases the number of strains which need to be characterized by PFGE in order to improve discrimination beyond the serovar level. Moreover, serotyping is widely used for long-term microbiological surveillance of human listeriosis. For the food industry, where the presence of L. monocytogenes is a big concern, tracing contaminating strains within the food chain and the plant environment is of primary importance. Again serotyping is often used as a first-line typing method. Although 13 serovars are described for the species L. monocytogenes, at least 95% of the strains isolated from foods and patients are of serovars 1/2a, 1/2b, 1/2c, and 4b (12,21,22). Routine analysis of L. monocytogenes by serotyping with traditional agglutination methods is limited by cost, availability, and the need for technical expertise to perform the assay. Furthermore, the reproducibility of serotyping is not always satisfactory. Schonberg et al. (20) concluded in a multicenter study that a critical need exists for high-quality antisera. A new enzyme-linked immunosorbent assay serotyping format used in conjunction with a commercially available kit to make serotyping more efficient and more ...
Whole genome sequencing (WGS) offers the potential to predict antimicrobial susceptibility from a single assay. The European Committee on Antimicrobial Susceptibility Testing established a subcommittee to review the current development status of WGS for bacterial antimicrobial susceptibility testing (AST). The published evidence for using WGS as a tool to infer antimicrobial susceptibility accurately is currently either poor or non-existent and the evidence / knowledge base requires significant expansion. The primary comparators for assessing genotypic-phenotypic concordance from WGS data should be changed to epidemiological cut-off values in order to improve differentiation of wild-type from non-wild-type isolates (harbouring an acquired resistance). Clinical breakpoints should be a secondary comparator. This assessment will reveal whether genetic predictions could also be used to guide clinical decision making. Internationally agreed principles and quality control (QC) metrics will facilitate early harmonization of analytical approaches and interpretive criteria for WGS-based predictive AST. Only data sets that pass agreed QC metrics should be used in AST predictions. Minimum performance standards should exist and comparative accuracies across different WGS laboratories and processes should be measured. To facilitate comparisons, a single public database of all known resistance loci should be established, regularly updated and strictly curated using minimum standards for the inclusion of resistance loci. For most bacterial species the major limitations to widespread adoption for WGS-based AST in clinical laboratories remain the current high-cost and limited speed of inferring antimicrobial susceptibility from WGS data as well as the dependency on previous culture because analysis directly on specimens remains challenging. For most bacterial species there is currently insufficient evidence to support the use of WGS-inferred AST to guide clinical decision making. WGS-AST should be a funding priority if it is to become a rival to phenotypic AST. This report will be updated as the available evidence increases.
Colistin resistance is rare in2؉ induction conditions. pmrB gene knockout mutants of the colistin-resistant ATCC 19606 derivative showed >100-fold increased susceptibility to colistin and 5-fold decreased expression of pmrC; they also lacked the addition of phosphoethanolamine to lipid A. We conclude that the development of a moderate level of colistin resistance in A. baumannii requires distinct genetic events, including (i) at least one point mutation in pmrB, (ii) upregulation of pmrAB, and (iii) expression of pmrC, which lead to addition of phosphoethanolamine to lipid A.
Ertapenem resistance was exclusively due to combinations of beta-lactamases with impermeability caused by loss of OMPs. Efflux was not implicated and there was no national spread of resistant clones.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.